奥锐特20240513

Summary of the Conference Call for Aorite Pharmaceutical Co., Ltd. Company Overview - Aorite Pharmaceutical Co., Ltd. held a conference call to discuss its 2023 annual results and the expected performance for the first quarter of 2024 [1] Key Points and Arguments - The company provided an overview of its basic situation and operational performance for 2023 and the first quarter of 2024 [1] Other Important Content - No additional specific financial data, industry trends, or detailed operational insights were provided in the excerpt [1]